GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » Margin of Safety % (DCF FCF Based)

Obio Technology (shanghai) (SHSE:688238) Margin of Safety % (DCF FCF Based) : N/A (As of Dec. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Obio Technology (shanghai) Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Obio Technology (shanghai)'s Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Obio Technology (shanghai)'s Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Obio Technology (shanghai)'s Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Obio Technology (shanghai)'s Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Obio Technology (shanghai)'s Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Obio Technology (shanghai)'s Margin of Safety % (DCF FCF Based) falls into.


Obio Technology (shanghai) Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Obio Technology (shanghai)'s Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Obio Technology (shanghai) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
SHSE:688293 SHSE:603590 SHSE:688222 SZSE:300497 SHSE:688197 SHSE:688513 SZSE:300653 SHSE:688488 SZSE:301333 SHSE:688075 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318
Website
https://www.obiosh.com
Obio Technology (shanghai) Corp Ltd is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Executives
You Qing Rui Directors, senior managers
Pan Jun Yi Director
Yang Jia Li Core technical personnel

Obio Technology (shanghai) Headlines

No Headlines